Evidence map›Paper›PMID 23675294›Full record

ArticlePLoS pathogens2013

Identification of targets of CD8⁺ T cell responses to malaria liver stages by genome-wide epitope profiling.

Julius Clemence R Hafalla, Karolis Bauza, Johannes Friesen, Gloria Gonzalez-Aseguinolaza, Adrian V S Hill, Kai Matuschewski

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 71 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Malaria: past, present, and future.Signal transduction and targeted therapy · 2025
    Review
  5. Androgens inhibit protective CD8Nature communications · 2025
    Article
  6. Article
  7. CD8Frontiers in immunology · 2024
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Importance of the Immunodominant CD8Infection and immunity · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. T cell-mediated immunity to malaria.Nature reviews. Immunology · 2019
    Review
  18. The Liver-StageFrontiers in immunology · 2019
    Article
  19. Comprehensive Review of HumanFrontiers in immunology · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

Julius Clemence R HafallaDepartment of Immunology and Infection, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom. Julius.Hafalla@lshtm.ac.uk
Karolis Bauza
Johannes Friesen
Gloria Gonzalez-Aseguinolaza
Adrian V S Hill
Kai Matuschewski
University of Oxford · GBHumboldt-Universität zu Berlin · DELondon School of Hygiene & Tropical Medicine · GBMax Planck Institute for Infection Biology · DEUniversidad de Navarra · ES

Funding

Wellcome Trust 090532Wellcome Trust 095540
6 · The paper itself

Abstract

CD8⁺ T cells mediate immunity against Plasmodium liver stages. However, the paucity of parasite-specific epitopes of CD8⁺ T cells has limited our current understanding of the mechanisms influencing the generation, maintenance and efficiency of these responses. To identify antigenic epitopes in a stringent murine malaria immunisation model, we performed a systematic profiling of H(2b)-restricted peptides predicted from genome-wide analysis. We describe the identification of Plasmodium berghei (Pb) sporozoite-specific gene 20 (S20)- and thrombospondin-related adhesive protein (TRAP)-derived peptides, termed PbS20₃₁₈ and PbTRAP₁₃₀ respectively, as targets of CD8⁺ T cells from C57BL/6 mice vaccinated by whole parasite strategies known to protect against sporozoite challenge. While both PbS20₃₁₈ and PbTRAP₁₃₀ elicit effector and effector memory phenotypes in both the spleens and livers of immunised mice, only PbTRAP₁₃₀-specific CD8⁺ T cells exhibit in vivo cytotoxicity. Moreover, PbTRAP₁₃₀-specific, but not PbS20₃₁₈-specific, CD8⁺ T cells significantly contribute to inhibition of parasite development. Prime/boost vaccination with PbTRAP demonstrates CD8⁺ T cell-dependent efficacy against sporozoite challenge. We conclude that PbTRAP is an immunodominant antigen during liver-stage infection. Together, our results underscore the presence of CD8⁺ T cells with divergent potencies against distinct Plasmodium liver-stage epitopes. Our identification of antigen-specific CD8⁺ T cells will allow interrogation of the development of immune responses against malaria liver stages.

Indexed as

Amino Acid SequenceAnimalsAntigens, ProtozoanCD8-Positive T-LymphocytesEpitopes, T-LymphocyteGenome-Wide Association StudyLiverMalariaMiceMice, Inbred C57BLPlasmodium bergheiProtozoan ProteinsSporozoitesAntigens, ProtozoanEpitopes, T-LymphocyteProtozoan Proteinsthrombospondin-related adhesive protein, protozoan

Identifiers

PMID23675294
PMCPMC3649980
OpenAlexW1987858349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.